Animalcare Group plc (LON:ANCR)

Market Cap	173.16M
Revenue (ttm)	81.07M
Net Income (ttm)	2.98M
Shares Out	68.99M
EPS (ttm)	0.05
PE Ratio	55.61
Forward PE	17.51
Dividend	0.05 (2.07%)
Ex-Dividend Date	Oct 16, 2025

Volume	10,486
Average Volume	1,088,607
Open	251.30
Previous Close	251.00
Day's Range	250.13 - 251.44
52-Week Range	202.00 - 305.35
Beta	0.38
RSI	57.93
Earnings Date	Dec 24, 2025

About Animalcare Group

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jennifer Ann Winter
• Employees: 201
• Stock Exchange: London Stock Exchange
• Ticker Symbol: ANCR

Financial Performance

In 2024, Animalcare Group's revenue was 74.23 million, an increase of 4.94% compared to the previous year's 70.73 million. Earnings were 18.49 million, an increase of 1442.45%.